Publications en collaboration avec des chercheurs de Universitat de Barcelona (69)

2024

  1. Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients: Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration–dose ratio

    Nefrologia , Vol. 44, Núm. 2, pp. 204-216

2023

  1. A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

    Kidney International, Vol. 104, Núm. 4, pp. 840-850

  2. Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma

    Pharmaceutics, Vol. 15, Núm. 1

  3. CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

    Pharmaceutics, Vol. 15, Núm. 12

  4. Cytotoxicity of osmium(ii) and cycloosmated half-sandwich complexes from 1-pyrenyl-containing phosphane ligands

    Dalton Transactions, Vol. 52, Núm. 24, pp. 8391-8401

  5. Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice

    Diabetes, Obesity and Metabolism, Vol. 25, Núm. 11, pp. 3268-3278

  6. Small molecule anion carriers facilitate lactate transport in model liposomes and cells

    iScience, Vol. 26, Núm. 10

  7. Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes

    Journal of Biological Inorganic Chemistry, Vol. 28, Núm. 4, pp. 403-420

  8. The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

    Pharmaceutics, Vol. 15, Núm. 5

  9. Thiosemicarbazonecopper/Halido Systems: Structure and DFT Analysis of the Magnetic Coupling

    Inorganics, Vol. 11, Núm. 1

2022

  1. A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer

    Cancers, Vol. 14, Núm. 14

  2. Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models

    International journal of molecular sciences, Vol. 23, Núm. 15

  3. Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation

    Frontiers in Immunology, Vol. 13

2021

  1. Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in murine models

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-19

  2. Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation

    Frontiers in Pharmacology, Vol. 12

  3. Multi-smart and scalable bioligands-free nanomedical platform for intratumorally targeted tambjamine delivery, a difficult to administrate highly cytotoxic drug

    Biomedicines, Vol. 9, Núm. 5

  4. Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells

    International Immunopharmacology, Vol. 91

  5. Self-Assembly Hydrosoluble Coronenes: A Rich Source of Supramolecular Turn-On Fluorogenic Sensing Materials in Aqueous Media

    Organic Letters, Vol. 23, Núm. 22, pp. 8727-8732

  6. Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients

    Clinical Pharmacology and Therapeutics, Vol. 110, Núm. 1, pp. 238-247

  7. Tambjamines and prodiginines: Biocidal activity against trypanosoma cruzi

    Pharmaceutics, Vol. 13, Núm. 5